Executive Gives Herself $16 Million Raise While Increasing Life-Saving EpiPen Price Over 400%
This can't be a coincidence.
Select the newsletters you’d like to receive. Then, add your email to sign up.
You are now subscribed
Your newsletter sign-up was successful
Want to add more newsletters?
Delivered daily
Marie Claire Daily
Get exclusive access to fashion and beauty trends, hot-off-the-press celebrity news, and more.
Sent weekly on Saturday
Marie Claire Self Checkout
Exclusive access to expert shopping and styling advice from Nikki Ogunnaike, Marie Claire's editor-in-chief.
Once a week
Maire Claire Face Forward
Insider tips and recommendations for skin, hair, makeup, nails and more from Hannah Baxter, Marie Claire's beauty director.
Once a week
Livingetc
Your shortcut to the now and the next in contemporary home decoration, from designing a fashion-forward kitchen to decoding color schemes, and the latest interiors trends.
Delivered Daily
Homes & Gardens
The ultimate interior design resource from the world's leading experts - discover inspiring decorating ideas, color scheming know-how, garden inspiration and shopping expertise.
As if you need another reason to shake your head while reading the news. Mylan, the pharmaceutical company that provides the marketplace with anti-allergy EpiPens, has hiked the prices of the medication more than 400 percent in the last eight years. Not only that, but filing documents show that salaries of top execs at Mylan Pharmaceuticals *also* skyrocketed over the last eight years. (Interesting...)
CEO Heather Bresch's salary ballooned 261 percent as she raked in more than $18 million last year compared to just over $2 million in 2007, according to NBC News. The price of EpiPens also increased from $56.64 to a whopping $317.82 since Mylan acquired the patent in 2007 and quietly collected a market monopoly on the life-saving product.
Due to the price hike, many patients requiring the device have resorted to DIY methods and buying overseas.
Adding insult to injury, previous inquests into Mylan revealed more suspicious activity. A 2008 inquiry found that while Bresch did not fully complete her coursework for her MBA from West Virginia University, the school received a $20 million dollar donation from a company chairman in 2003.
On Monday, a group of U.S. senators called for a probe into Mylan's business practices and demanded Bresch answer for the company's actions. Mylan has not yet responded to requests for a Senate hearing.
If you are (justifiably) horrified by this, you can sign non-profit organization The Other 98%'s petition to decrease EpiPen prices here.
Follow Marie Claire on Facebook for the latest celeb news, beauty tips, fascinating reads, livestream video, and more.
Get exclusive access to fashion and beauty trends, hot-off-the-press celebrity news, and more.
Simedar Jackson is an esthetician, content creator, and lover of sci-fi fiction living in Brooklyn, New York. She is passionate about creating space for Black and Brown people in the beauty and wellness industries by providing access to culturally nuanced education and services that meet their needs. You can find them doing their skincare routine, reminding friends to reapply SPF, and watching reruns of Love Island.
